Selected research
Industry Growth & Trends
Global Nasal Spray Flu Vaccines Industry Growth and Trends Forecast to 2032
Market perspective
The global Nasal Spray Flu Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Nasal Spray Flu Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Nasal Spray Flu Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nasal Spray Flu Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Nasal Spray Flu Vaccines include Abbott, GlaxoSmithKline, AstraZeneca, Serum Institute of India, Sanofi Pasteur and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Nasal Spray Flu Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nasal Spray Flu Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nasal Spray Flu Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nasal Spray Flu Vaccines.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Nasal Spray Flu Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nasal Spray Flu Vaccines Market by Company
Abbott
GlaxoSmithKline
AstraZeneca
Serum Institute of India
Sanofi Pasteur
CSL
Nasal Spray Flu Vaccines Segment by Type
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
Nasal Spray Flu Vaccines Segment by Application
Clinic
Hospital
Public Health Agency
Other
Nasal Spray Flu Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Spray Flu Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nasal Spray Flu Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Spray Flu Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nasal Spray Flu Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Nasal Spray Flu Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Trivalent Flu Vaccine
- Quadrivalent Flu Vaccine
Applications
- Clinic
- Hospital
- Public Health Agency
- Other
Companies covered
- Abbott
- GlaxoSmithKline
- AstraZeneca
- Serum Institute of India
- Sanofi Pasteur
- CSL
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Nasal Spray Flu Vaccines Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Nasal Spray Flu Vaccines Sales Estimates and Forecasts (2021-2032)
- 1.3 Nasal Spray Flu Vaccines Market by Type
- 1.3.1 Trivalent Flu Vaccine
- 1.3.2 Quadrivalent Flu Vaccine
- 1.4 Global Nasal Spray Flu Vaccines Market Size by Type
- 1.4.1 Global Nasal Spray Flu Vaccines Market Size Overview by Type (2021-2032)
- 1.4.2 Global Nasal Spray Flu Vaccines Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Nasal Spray Flu Vaccines Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Nasal Spray Flu Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Nasal Spray Flu Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Nasal Spray Flu Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Nasal Spray Flu Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Nasal Spray Flu Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Nasal Spray Flu Vaccines Industry Trends
- 2.2 Nasal Spray Flu Vaccines Industry Drivers
- 2.3 Nasal Spray Flu Vaccines Industry Opportunities and Challenges
- 2.4 Nasal Spray Flu Vaccines Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Nasal Spray Flu Vaccines Revenue (2021-2026)
- 3.2 Global Top Players by Nasal Spray Flu Vaccines Sales (2021-2026)
- 3.3 Global Top Players by Nasal Spray Flu Vaccines Price (2021-2026)
- 3.4 Global Nasal Spray Flu Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nasal Spray Flu Vaccines Major Company Production Sites & Headquarters
- 3.6 Global Nasal Spray Flu Vaccines Company, Product Type & Application
- 3.7 Global Nasal Spray Flu Vaccines Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Nasal Spray Flu Vaccines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Nasal Spray Flu Vaccines Players Market Share by Revenue in 2025
- 3.8.3 2025 Nasal Spray Flu Vaccines Tier 1, Tier 2, and Tier 3
4 Nasal Spray Flu Vaccines Regional Status and Outlook
- 4.1 Global Nasal Spray Flu Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Nasal Spray Flu Vaccines Historic Market Size by Region
- 4.2.1 Global Nasal Spray Flu Vaccines Sales in Volume by Region (2021-2026)
- 4.2.2 Global Nasal Spray Flu Vaccines Sales in Value by Region (2021-2026)
- 4.2.3 Global Nasal Spray Flu Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Nasal Spray Flu Vaccines Forecasted Market Size by Region
- 4.3.1 Global Nasal Spray Flu Vaccines Sales in Volume by Region (2027-2032)
- 4.3.2 Global Nasal Spray Flu Vaccines Sales in Value by Region (2027-2032)
- 4.3.3 Global Nasal Spray Flu Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nasal Spray Flu Vaccines by Application
- 5.1 Nasal Spray Flu Vaccines Market by Application
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Public Health Agency
- 5.1.4 Other
- 5.2 Global Nasal Spray Flu Vaccines Market Size by Application
- 5.2.1 Global Nasal Spray Flu Vaccines Market Size Overview by Application (2021-2032)
- 5.2.2 Global Nasal Spray Flu Vaccines Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Nasal Spray Flu Vaccines Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Nasal Spray Flu Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Nasal Spray Flu Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Nasal Spray Flu Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Nasal Spray Flu Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Nasal Spray Flu Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Nasal Spray Flu Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Abbott Nasal Spray Flu Vaccines Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 GlaxoSmithKline
- 6.2.1 GlaxoSmithKline Company Information
- 6.2.2 GlaxoSmithKline Business Overview
- 6.2.3 GlaxoSmithKline Nasal Spray Flu Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 GlaxoSmithKline Nasal Spray Flu Vaccines Product Portfolio
- 6.2.5 GlaxoSmithKline Recent Developments
- 6.3 AstraZeneca
- 6.3.1 AstraZeneca Company Information
- 6.3.2 AstraZeneca Business Overview
- 6.3.3 AstraZeneca Nasal Spray Flu Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 AstraZeneca Nasal Spray Flu Vaccines Product Portfolio
- 6.3.5 AstraZeneca Recent Developments
- 6.4 Serum Institute of India
- 6.4.1 Serum Institute of India Company Information
- 6.4.2 Serum Institute of India Business Overview
- 6.4.3 Serum Institute of India Nasal Spray Flu Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Serum Institute of India Nasal Spray Flu Vaccines Product Portfolio
- 6.4.5 Serum Institute of India Recent Developments
- 6.5 Sanofi Pasteur
- 6.5.1 Sanofi Pasteur Company Information
- 6.5.2 Sanofi Pasteur Business Overview
- 6.5.3 Sanofi Pasteur Nasal Spray Flu Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sanofi Pasteur Nasal Spray Flu Vaccines Product Portfolio
- 6.5.5 Sanofi Pasteur Recent Developments
- 6.6 CSL
- 6.6.1 CSL Company Information
- 6.6.2 CSL Business Overview
- 6.6.3 CSL Nasal Spray Flu Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 CSL Nasal Spray Flu Vaccines Product Portfolio
- 6.6.5 CSL Recent Developments
7 North America by Country
- 7.1 North America Nasal Spray Flu Vaccines Sales by Country
- 7.1.1 North America Nasal Spray Flu Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Nasal Spray Flu Vaccines Sales by Country (2021-2026)
- 7.1.3 North America Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032)
- 7.2 North America Nasal Spray Flu Vaccines Market Size by Country
- 7.2.1 North America Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Nasal Spray Flu Vaccines Market Size by Country (2021-2026)
- 7.2.3 North America Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Nasal Spray Flu Vaccines Sales by Country
- 8.1.1 Europe Nasal Spray Flu Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Nasal Spray Flu Vaccines Sales by Country (2021-2026)
- 8.1.3 Europe Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032)
- 8.2 Europe Nasal Spray Flu Vaccines Market Size by Country
- 8.2.1 Europe Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Nasal Spray Flu Vaccines Market Size by Country (2021-2026)
- 8.2.3 Europe Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Nasal Spray Flu Vaccines Sales by Country
- 9.1.1 Asia-Pacific Nasal Spray Flu Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Nasal Spray Flu Vaccines Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Nasal Spray Flu Vaccines Market Size by Country
- 9.2.1 Asia-Pacific Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Nasal Spray Flu Vaccines Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Nasal Spray Flu Vaccines Sales by Country
- 10.1.1 South America Nasal Spray Flu Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Nasal Spray Flu Vaccines Sales by Country (2021-2026)
- 10.1.3 South America Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032)
- 10.2 South America Nasal Spray Flu Vaccines Market Size by Country
- 10.2.1 South America Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Nasal Spray Flu Vaccines Market Size by Country (2021-2026)
- 10.2.3 South America Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Nasal Spray Flu Vaccines Sales by Country
- 11.1.1 Middle East and Africa Nasal Spray Flu Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Nasal Spray Flu Vaccines Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Nasal Spray Flu Vaccines Market Size by Country
- 11.2.1 Middle East and Africa Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Nasal Spray Flu Vaccines Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Nasal Spray Flu Vaccines Value Chain Analysis
- 12.1.1 Nasal Spray Flu Vaccines Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Nasal Spray Flu Vaccines Production Mode & Process
- 12.2 Nasal Spray Flu Vaccines Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Nasal Spray Flu Vaccines Distributors
- 12.2.3 Nasal Spray Flu Vaccines Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst